DRTSW Latest Press Releases

-- November 12, 2026 --

Alpha Tau to Host Investor Call to Review New Data from the Alpha DaRT Recurrent Glioblastoma REGAIN Trial Globe Newswire 8:30 AM

-- October 29, 2026 --

Alpha Tau Announces Inclusion in the Flagship TA-90 and TA-125 Indices of the Tel Aviv Stock Exchange Globe Newswire 12:14 PM

-- October 22, 2026 --

Alpha Tau and Samsung Medical Center Sign MOU to Explore Clinical Trial of Alpha DaRT for Pancreatic Cancer Patients in Korea Globe Newswire 8:30 AM

-- October 19, 2026 --

Alpha Tau Announces FDA Approval to Expand Alpha DaRT U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting Globe Newswire 8:30 AM

-- October 5, 2026 --

Alpha Tau to Participate in October Investor Conferences Globe Newswire 9:45 AM

-- September 2, 2026 --

Alpha Tau to Participate in September Investor Conferences Globe Newswire 8:00 AM

-- August 31, 2026 --

Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT Following Strong Demand and Multiple Expansions Globe Newswire 8:00 AM

-- August 10, 2026 --

Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 4:01 PM

Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE) Globe Newswire 8:00 AM

-- July 21, 2026 --

Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study's Pre-Specified Threshold for Success Globe Newswire 8:30 AM

-- July 15, 2026 --

Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center Globe Newswire 8:30 AM

-- June 23, 2026 --

Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT at Hadassah University Medical Center in Israel Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes